title: [Cardiorenal syndrome type 2--literature review].
abstract: We performed literature search in the Pubmed database in July 2013. The key word used for search was cardiorenal syndrome type 2, limited to English language and humans. Over the last decade, a significant advance in the understanding of the cardiorenal syndrome has been achieved. However, precise pathogenesis remains to be clarified. Current treatment in postponing progression of cardiorenal syndrome type 2 is not efficient, although novel drugs like levosimendan and tezosentan seem promising. Future research is necessary to determine their role in the treatment of cardiorenal syndrome type 2.
authors.forename: Dragan
authors.initials: D
authors.lastname: Novosel
authors.forename: Nikolina
authors.initials: N
authors.lastname: Bašić-Jukić
authors.forename: Zorin
authors.initials: Z
authors.lastname: Makarović
authors.forename: Sandra
authors.initials: S
authors.lastname: Makarović
mesh_terms: D059347:Cardio-Renal Syndrome / Q000175:diagnosis* / Q000453:epidemiology* / Q000517:prevention & control; D018450:Disease Progression; D014943:Global Health; D006334:Heart Function Tests / Q000379:methods*; D006801:Humans; D007677:Kidney Function Tests / Q000379:methods*; D011379:Prognosis; D012720:Severity of Illness Index